XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
2.160
+0.030 (1.41%)
At close: Oct 2, 2026, 4:00 PM EDT
2.150
-0.010 (-0.46%)
After-hours: Oct 2, 2026, 4:10 PM EDT
XTL Biopharmaceuticals Employees
As of December 31, 2025, XTL Biopharmaceuticals had 5 total employees, including 4 full-time and 1 part-time employees. The number of employees decreased by 5 or -50.00% compared to the previous year.
Employees
5
Change (1Y)
-5
Growth (1Y)
-50.00%
Revenue / Employee
n/a
Profits / Employee
-$1,393,800
Market Cap
8.16M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 5 | -5 | -50.00% | 4 | 1 |
| Dec 31, 2024 | 10 | 3 | 42.86% | 10 | 0 |
| Dec 31, 2016 | 7 | 1 | 16.67% | 2 | 5 |
| Dec 31, 2015 | 6 | - | - | 3 | 3 |
Related Stocks
| Company Name | Employees |
|---|---|
| Longeveron | 38 |
| Enlivex | 34 |
| NeuroSense Therapeutics | 17 |
| FibroBiologics | 15 |
| Soligenix | 14 |
| Azitra | 13 |
| Ensysce Biosciences | 10 |
| CNS Pharmaceuticals | 8 |
XTLB News
- 3 months ago - XTL BioPharma Closes Acquisition Of Psyga Bio; Shifts Focus To Psychedelic Therapies - Nasdaq
- 3 months ago - XTL Completed the Acquisition of Psyga Bio Ltd. - GlobeNewsWire
- 4 months ago - XTL Biopharmaceuticals (XTLB) Faces Nasdaq Compliance Challenges Amid Stock Surge - GuruFocus
- 4 months ago - XTL Announces Receipt of Staff Delist Determination from Nasdaq - GlobeNewsWire
- 5 months ago - 3 Penny Stocks to Watch Now, 4/30/26 - TipRanks
- 5 months ago - XTL Biopharmaceuticals (XTLB) to Acquire Psyga Bio, Shares Surge 58.7% - GuruFocus
- 5 months ago - XTL Biopharmaceuticals to acquire Psyga Bio - TheFly
- 5 months ago - XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies - GlobeNewsWire